TickerFacts.

Immucell Corp (ICCC): R&D Expense

Annual figures by period end, from SEC filings.

$3.04M
Year ended 2025-12-31
$1.89M
Trailing 12 months to 2026-06-30
-12.2%
3-year compound annual growth
-6.9%
5-year compound annual growth
+9.4%
10-year compound annual growth
$4.49M2009-12-31: $1.64M2010-12-31: $1.49M2011-12-31: $1.72M2012-12-31: $917.6K2013-12-31: $1.15M2014-12-31: $2.18M2015-12-31: $1.24M2016-12-31: $1.24M2017-12-31: $2.05M2018-12-31: $3.52M2019-12-31: $3.69M2020-12-31: $4.35M2021-12-31: $4.17M2022-12-31: $4.49M2023-12-31: $4.39M2024-12-31: $3.90M2025-12-31: $3.04M$3.04M
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$3.04M-22.0%2026-03-30, From 2025-01-01
2024-12-31$3.90M-11.3%2026-03-30, From 2024-01-01
2023-12-31$4.39M-2.2%2025-03-28, From 2023-01-01
2022-12-31$4.49M+7.8%2024-04-01, From 2022-01-01
2021-12-31$4.17M-4.3%2023-03-29, From 2021-01-01
2020-12-31$4.35M+18.1%2022-03-30, From 2020-01-01
2019-12-31$3.69M+4.9%2021-03-30, From 2019-01-01
2018-12-31$3.52M+71.8%2020-03-27, From 2018-01-01
2017-12-31$2.05M+64.5%2019-03-22, From 2017-01-01
2016-12-31$1.24M+0.7%2018-03-29, From 2016-01-01
2015-12-31$1.24M-43.3%2017-03-30, From 2015-01-01
2014-12-31$2.18M+88.8%2016-03-25, From 2014-01-01
2013-12-31$1.15M+25.8%2016-03-25, From 2013-01-01
2012-12-31$917.6K-46.7%2015-03-26, From 2012-01-01
2011-12-31$1.72M+15.2%2014-03-26, From 2011-01-01
2010-12-31$1.49M-9.2%2013-03-28, From 2010-01-01
2009-12-31$1.64Mn/a2012-03-27, From 2009-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Immucell Corp (ICCC)2025-12-31$3.04M-22.0%
Alpha Teknova, Inc. (TKNO)2025-12-31$2.20M-20.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$388.86M-16.6%
Aspira Women's Health Inc. (AWHL)2025-12-31$2.88M-11.9%
Anbio Biotechnology (NNNN)2025-12-31$201.3K-55.7%
Biomerica Inc (BMRA)2026-05-31$788.0K-23.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$15.90M+61.6%
Volitionrx Ltd (VNRX)2025-12-31$10.08M-30.0%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$245.07M+49.8%

Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗